The MedicX Fund Limited Total voting rights (4292T)
January 05 2017 - 3:00AM
UK Regulatory
TIDMMXF
RNS Number : 4292T
The MedicX Fund Limited
05 January 2017
For immediate release
5 January 2017
MedicX Fund Limited
("MedicX Fund", "the Fund" or "the Company")
Total voting rights
In accordance with the Financial Conduct Authority's Disclosure
and Transparency Rules, the total number of ordinary shares of the
Company in issue as at 31 December 2016 was 398,368,855 (excluding
treasury shares) with each share holding one voting right.
The above figure may be used by shareholders as the denominator
for the calculations by which they will determine if they are
required to notify their interest in, or a change to their interest
in the Company, under the Disclosure and Transparency Rules.
The Company also holds 7,783,327 ordinary shares in treasury and
has 12,081,109 ordinary shares of no par value remaining under its
block listing facility.
End
For further information please contact:
MedicX Fund +44 (0) 1481 723 450
David Staples, Chairman
Octopus Healthcare Group +44 (0) 20 3142 4820
Mike Adams, Chief Executive Officer
Buchanan +44 (0) 20 7466 5000
Charles Ryland/Victoria Hayns
Information on MedicX Fund Limited
MedicX Fund Limited ("MXF", "MedicX Fund", "the Fund" or "the
Company", or together with its subsidiaries, the "Group") is the
specialist primary care infrastructure investor in modern,
purpose-built primary healthcare properties in the United Kingdom
and Ireland, listed on the London Stock Exchange, with a portfolio
comprising 152 properties.
The Investment Adviser to the Company is Octopus Healthcare
Adviser Ltd, which is part of the Octopus Healthcare group. Octopus
Healthcare invests in and develops properties as well as creating
partnerships to deliver innovative healthcare buildings to improve
the health, wealth and wellbeing of the UK. It currently manages
over GBP1 billion of healthcare investments across a number of
platforms, with a focus on four core areas: GP surgeries, care
homes, retirement housing and private hospitals. Octopus Healthcare
is part of the Octopus group, a fast-growing UK fund management
business with leading positions in several specialist sectors
including healthcare property, energy, property finance and smaller
company investing. Octopus manages GBP6 billion of funds for more
than 50,000 retail and institutional investors.
Octopus Healthcare Adviser Ltd is authorised and regulated by
the Financial Conduct Authority.
The Company's website address is www.medicxfund.com. Neither the
contents of the Company's website nor the contents of any website
accessible from hyperlinks on the Company's website (or any other
website), nor the contents of any website accessible from
hyperlinks within this announcement, are incorporated into, or
forms part of, this announcement.
The Company's Legal Entity Identifier is
2138008POF35FTNFCB25.
This information is provided by RNS
The company news service from the London Stock Exchange
END
TVRUGUQCGUPMURA
(END) Dow Jones Newswires
January 05, 2017 04:00 ET (09:00 GMT)
Medicx (LSE:MXF)
Historical Stock Chart
From Apr 2024 to May 2024
Medicx (LSE:MXF)
Historical Stock Chart
From May 2023 to May 2024